MedTrace Logo

Oral Iohexol for Fecal/Fluid Tagging for CT Colonography: A Study to Improve Image Quality by Preventing Colonic Bubbles

NCT01790139 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2014-03-26

No results posted yet for this study

Summary

To determine whether colonic bubbles associated with CT colonography performed with iohexol for fecal/fluid tagging could be reduced by adding simethicone to the standard cathartic preparation.

Conditions

  • Colorectal Neoplasms

Interventions

DRUG

Oral simethicone

10 mL of simethicone is administered as an agent to prevent colonic bubbles

Sponsors & Collaborators

  • GE Healthcare

    collaborator INDUSTRY

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Seong Ho Park, MD · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-11-30
Completion
2014-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01790139 on ClinicalTrials.gov